54 627 Pill - white capsule/oblong, 14mm
Pill with imprint 54 627 is White, Capsule/Oblong and has been identified as Everolimus 7.5 mg. It is supplied by Hikma Pharmaceuticals PLC.
Everolimus is used in the treatment of Neuroendocrine Carcinoma; Breast Cancer; Organ Transplant, Rejection Prophylaxis; Pancreatic Cancer; Renal Angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 627
Everolimus
- Imprint
- 54 627
- Strength
- 7.5 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- MTOR inhibitors, Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Hikma Pharmaceuticals PLC
- Manufacturer
- West-Ward Columbus Inc.
- National Drug Code (NDC)
- 00054-0497
More about everolimus
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (29)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: mTOR inhibitors
- Breastfeeding
- En español
Patient resources
- Everolimus drug information
- Everolimus Tablets (Afinitor)
- Everolimus Tablets (Zortress)
- Everolimus Tablets For Oral Suspension
Other brands
Afinitor, Zortress, Afinitor Disperz
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
